New Medication Treatment for Stimulant Dependence

NCT00689572 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Cocaine Dependence

Interventions

DRUG: Ondansetron
DRUG: Placebo

Sponsor

University of Virginia

Collaborators

[object Object]